Fleury Management

Ms. Jeane Mike Tsutsui serves as Chief Executive Officer and President of Executive Board at Fleury S.A. and served as its Brands Officer since 2019. She is also an Advisor at Kortex Ventures. Ms. Tsutsui...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Jeane Tsutsui	CEO & President of Executive Board	no data	no data	no data
Jose de Almeida Filippo	CFO, Investor Relations Officer & Member of Executive Board	2.9yrs	no data	no data
Claudio Prado	Executive Director of New Links & Member of Executive Board	8.2yrs	no data	no data
Edgar Rizzatti	Medical	6.8yrs	no data	no data
Roberto Meirelles	L2L & Operations Support Officer and Member of Executive Board	1.4yrs	no data	no data
Fernando Camargo	Secretary	no data	no data	no data

4.9yrs

Average Tenure

Experienced Management: FLRY3's management team is considered experienced (4.9 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Rui de Barros Maciel	External Director	5.8yrs	no data	no data
Samuel dos Santos	External Director	no data	no data	no data
Ivan Gontijo	Director	no data	no data	no data
Manoel Peres	Alternate Director	no data	no data	no data
Marcio Mendes	Chairman	5.8yrs	no data	0.73% R$ 54.5m
Fernando Alberto	Vice-Chairman	24.8yrs	no data	0.65% R$ 48.5m
Octavio de Lazari	Alternate Director	7.1yrs	no data	no data
Luiz Carlos Cappi	External Director	6yrs	no data	no data
Joao Goncalves Teixeira	Independent Director	2.9yrs	no data	no data
Regina Pardini	Independent Director	1.8yrs	no data	no data
Victor Pardini	Independent Director	1.8yrs	no data	no data
Marcio de Paula Ricardo	Independent Director	no data	no data	no data

5.8yrs

Average Tenure

61yo

Average Age

Experienced Board: FLRY3's board of directors are considered experienced (5.8 years average tenure).

Fleury Management

Management criteria checks 2/4

Key information

Recent management updates

Less than half of directors are independent

Less than half of directors are independent

High number of new directors

Recent updates

We Think Fleury's (BVMF:FLRY3) Profit Is Only A Baseline For What They Can Achieve

Third quarter 2024 earnings: Revenues miss analyst expectations

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Fleury S.A.'s (BVMF:FLRY3) Price Is Out Of Tune With Earnings

Second quarter 2024 earnings released

Now 20% undervalued

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

First quarter 2024 earnings released

The Price Is Right For Fleury S.A. (BVMF:FLRY3)

Concerns Surrounding Fleury's (BVMF:FLRY3) Performance

Upcoming dividend of R$0.15 per share

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Now 22% undervalued after recent price drop

Fleury S.A. to Report Q3, 2024 Results on Nov 07, 2024

Earnings Tell The Story For Fleury S.A. (BVMF:FLRY3)

Consensus EPS estimates increase by 10%, revenue downgraded

Third quarter 2023 earnings: Revenues in line with analyst expectations

Fleury (BVMF:FLRY3) Has A Pretty Healthy Balance Sheet

Consensus EPS estimates fall by 15%

Consensus EPS estimates increase by 14%

Second quarter 2023 earnings: Revenues in line with analyst expectations

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

New major risk - Shareholder dilution

Fleury S.A. to Report Q3, 2023 Results on Nov 09, 2023

First quarter 2023 earnings: Revenues exceed analyst expectations

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

We Think Fleury (BVMF:FLRY3) Can Stay On Top Of Its Debt

Less than half of directors are independent

Consensus forecasts updated

Consensus forecasts updated

Third quarter 2022 earnings: Revenues exceed analyst expectations

Fleury S.A. (BOVESPA:FLRY3) completed the acquisition of Methodos laboratory in Minas Gerais.

At R$18.27, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Second quarter 2022 earnings: Revenues exceed analyst expectations

Fleury (BVMF:FLRY3) Has Some Way To Go To Become A Multi-Bagger

Investor sentiment improved over the past week

Less than half of directors are independent

When Should You Buy Fleury S.A. (BVMF:FLRY3)?

First quarter 2022 earnings: Revenues exceed analyst expectations

Is Fleury (BVMF:FLRY3) Using Too Much Debt?

Return Trends At Fleury (BVMF:FLRY3) Aren't Appealing

Now 24% undervalued after recent price drop

Consensus forecasts updated

Price target decreased to R$20.75

Now 22% undervalued after recent price drop

Fleury S.A. to Report Fiscal Year 2021 Results on Mar 17, 2022

At R$19.12, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Now 20% undervalued after recent price drop

High number of new directors

Price target decreased to R$23.18

Returns On Capital Are Showing Encouraging Signs At Fleury (BVMF:FLRY3)

Fleury (BVMF:FLRY3) Seems To Use Debt Quite Sensibly

Price target decreased to R$26.38

Is Fleury S.A. (BVMF:FLRY3) Potentially Undervalued?

Investors Should Be Encouraged By Fleury's (BVMF:FLRY3) Returns On Capital

Fleury (BVMF:FLRY3) Seems To Use Debt Rather Sparingly

Second quarter 2021 earnings released

Is It Time To Consider Buying Fleury S.A. (BVMF:FLRY3)?

Consensus EPS estimates increase to R$1.19

First quarter 2021 earnings released

Does Fleury (BVMF:FLRY3) Have A Healthy Balance Sheet?

Fleury (BVMF:FLRY3) Shareholders Will Want The ROCE Trajectory To Continue

At R$25.16, Is It Time To Put Fleury S.A. (BVMF:FLRY3) On Your Watch List?

Should You Or Shouldn't You: A Dividend Analysis on Fleury S.A. (BVMF:FLRY3)

Analysts update estimates

New 90-day low: R$25.63

Only One Day Left To Cash In On Fleury's (BVMF:FLRY3) Dividend

Revenue and earnings beat expectations

Fleury S.A. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Full year 2020 earnings released

Fleury S.A. to Report Q4, 2020 Results on Feb 25, 2021